Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

p53-inducible SESTRINs might play opposite roles in the regulation of early and late stages of lung carcinogenesis.

Ding B, Haidurov A, Chawla A, Parmigiani A, van de Kamp G, Dalina A, Yuan F, Lee JH, Chumakov PM, Grossman SR, Budanov AV.

Oncotarget. 2019 Dec 10;10(65):6997-7009. doi: 10.18632/oncotarget.27367. eCollection 2019 Dec 10.

2.

Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes.

Zainutdinov SS, Kochneva GV, Netesov SV, Chumakov PM, Matveeva OV.

Oncolytic Virother. 2019 Jul 12;8:9-26. doi: 10.2147/OV.S176523. eCollection 2019.

3.

Oncolytic Activity of the Vaccine Strain of Type 3 Poliovirus on the Model of Rat Glioma C6 Cells.

Sosnovtseva AO, Zheltukhin AO, Lipatova AV, Chumakov PM, Chekhonin VP.

Bull Exp Biol Med. 2019 May;167(1):111-115. doi: 10.1007/s10517-019-04472-6. Epub 2019 Jun 8.

PMID:
31177454
4.

NLRX1 regulates TNF-α-induced mitochondria-lysosomal crosstalk to maintain the invasive and metastatic potential of breast cancer cells.

Singh K, Roy M, Prajapati P, Lipatova A, Sripada L, Gohel D, Singh A, Mane M, Godbole MM, Chumakov PM, Singh R.

Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1460-1476. doi: 10.1016/j.bbadis.2019.02.018. Epub 2019 Feb 23.

PMID:
30802640
5.

Relationship between Cell Receptors and Tumor Cell Sensitivity to Oncolytic Enteroviruses.

Lipatova AV, Le TH, Sosnovtseva AO, Babaeva FE, Kochetkov DV, Chumakov PM.

Bull Exp Biol Med. 2018 Nov;166(1):58-62. doi: 10.1007/s10517-018-4289-1. Epub 2018 Nov 18.

PMID:
30450519
6.

Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses.

Matveeva OV, Chumakov PM.

Rev Med Virol. 2018 Nov;28(6):e2008. doi: 10.1002/rmv.2008. Epub 2018 Sep 13. Review. Erratum in: Rev Med Virol. 2019 Jan;29(1):e2035.

7.

[Oncolytic Paramyxoviruses: Mechanism of Action, Preclinical and Clinical Studies].

Matveeva OV, Kochneva GV, Zainutdinov SS, Ilyinskaya GV, Chumakov PM.

Mol Biol (Mosk). 2018 May-Jun;52(3):360-379. doi: 10.7868/S0026898418030023. Review. Russian.

8.

NLRX1 resides in mitochondrial RNA granules and regulates mitochondrial RNA processing and bioenergetic adaptation.

Singh K, Sripada L, Lipatova A, Roy M, Prajapati P, Gohel D, Bhatelia K, Chumakov PM, Singh R.

Biochim Biophys Acta Mol Cell Res. 2018 Sep;1865(9):1260-1276. doi: 10.1016/j.bbamcr.2018.06.008. Epub 2018 Jun 20.

9.

Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study).

Ilyinskaya GV, Mukhina EV, Soboleva AV, Matveeva OV, Chumakov PM.

Front Vet Sci. 2018 Jun 4;5:116. doi: 10.3389/fvets.2018.00116. eCollection 2018.

10.

Expression of long non-coding RNA LINC00973 is consistently increased upon treatment of colon cancer cells with different chemotherapeutic drugs.

Zinovieva OL, Grineva EN, Prokofjeva MM, Karpov DS, Zheltukhin AO, Krasnov GS, Snezhkina AV, Kudryavtseva AV, Chumakov PM, Mashkova TD, Prassolov VS, Lisitsyn NA.

Biochimie. 2018 Aug;151:67-72. doi: 10.1016/j.biochi.2018.05.021. Epub 2018 Jun 2.

PMID:
29870803
11.

Profiling modifications for glioblastoma proteome using ultra-tolerant database search: Are the peptide mass shifts biologically relevant or chemically induced?

Tarasova IA, Chumakov PM, Moshkovskii SA, Gorshkov MV.

J Proteomics. 2019 Jan 16;191:16-21. doi: 10.1016/j.jprot.2018.05.010. Epub 2018 May 17.

PMID:
29777870
12.

Implication of KRT16, FAM129A and HKDC1 genes as ATF4 regulated components of the integrated stress response.

Evstafieva AG, Kovaleva IE, Shoshinova MS, Budanov AV, Chumakov PM.

PLoS One. 2018 Feb 8;13(2):e0191107. doi: 10.1371/journal.pone.0191107. eCollection 2018.

13.

Comparative proteomics as a tool for identifying specific alterations within interferon response pathways in human glioblastoma multiforme cells.

Tarasova IA, Tereshkova AV, Lobas AA, Solovyeva EM, Sidorenko AS, Gorshkov V, Kjeldsen F, Bubis JA, Ivanov MV, Ilina IY, Moshkovskii SA, Chumakov PM, Gorshkov MV.

Oncotarget. 2017 Nov 29;9(2):1785-1802. doi: 10.18632/oncotarget.22751. eCollection 2018 Jan 5.

14.

Binase treatment increases interferon sensitivity and apoptosis in SiHa cervical carcinoma cells by downregulating E6 and E7 human papilloma virus oncoproteins.

Mitkevich VA, Burnysheva KM, Petrushanko IY, Adzhubei AA, Schulga AA, Chumakov PM, Makarov AA.

Oncotarget. 2017 Aug 10;8(42):72666-72675. doi: 10.18632/oncotarget.20199. eCollection 2017 Sep 22.

15.

Bioselection of coxsackievirus B6 strain variants with altered tropism to human cancer cell lines.

Svyatchenko VA, Ternovoy VA, Kiselev NN, Demina AV, Loktev VB, Netesov SV, Chumakov PM.

Arch Virol. 2017 Nov;162(11):3355-3362. doi: 10.1007/s00705-017-3492-0. Epub 2017 Aug 1.

PMID:
28766058
16.

hsa-miR-4485 regulates mitochondrial functions and inhibits the tumorigenicity of breast cancer cells.

Sripada L, Singh K, Lipatova AV, Singh A, Prajapati P, Tomar D, Bhatelia K, Roy M, Singh R, Godbole MM, Chumakov PM, Singh R.

J Mol Med (Berl). 2017 Jun;95(6):641-651. doi: 10.1007/s00109-017-1517-5. Epub 2017 Feb 20.

PMID:
28220193
17.

Sensitivity of C6 Glioma Cells Carrying the Human Poliovirus Receptor to Oncolytic Polioviruses.

Sosnovtseva AO, Lipatova AV, Grinenko NF, Baklaushev VP, Chumakov PM, Chekhonin VP.

Bull Exp Biol Med. 2016 Oct;161(6):821-825. Epub 2016 Oct 26.

PMID:
27783287
18.

[Oncolytic viruses for therapy of malignant glioma].

Sosnovtceva AO, Grinenko NF, Lipatova AV, Chumakov PM, Chekhonin VP.

Biomed Khim. 2016 May;62(4):376-90. doi: 10.18097/PBMC20166204376. Review. Russian.

PMID:
27562991
19.

Intermedin/adrenomedullin 2 is a stress-inducible gene controlled by activating transcription factor 4.

Kovaleva IE, Garaeva AA, Chumakov PM, Evstafieva AG.

Gene. 2016 Sep 15;590(1):177-85. doi: 10.1016/j.gene.2016.06.037. Epub 2016 Jun 18.

PMID:
27328454
20.

Mitochondrial dysfunction induces SESN2 gene expression through Activating Transcription Factor 4.

Garaeva AA, Kovaleva IE, Chumakov PM, Evstafieva AG.

Cell Cycle. 2016;15(1):64-71. doi: 10.1080/15384101.2015.1120929.

21.

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.

Matveeva OV, Guo ZS, Shabalina SA, Chumakov PM.

Mol Ther Oncolytics. 2015;2. pii: 15011. Epub 2015 Jul 22.

22.

Oncolysis by paramyxoviruses: preclinical and clinical studies.

Matveeva OV, Guo ZS, Senin VM, Senina AV, Shabalina SA, Chumakov PM.

Mol Ther Oncolytics. 2015;2. pii: 150017. Epub 2015 Oct 21.

23.

Mechanisms of Oncolysis by Paramyxovirus Sendai.

Matveeva OV, Kochneva GV, Netesov SV, Onikienko SB, Chumakov PM.

Acta Naturae. 2015 Apr-Jun;7(2):6-16.

24.

[Oncotoxic proteins in cancer therapy: mechanisms of action].

Lezhnin YN, Kravchenko JE, Frolova EI, Chumakov PM, Chumakov SP.

Mol Biol (Mosk). 2015 Mar-Apr;49(2):264-78. Review. Russian.

25.

NLRX1 acts as tumor suppressor by regulating TNF-α induced apoptosis and metabolism in cancer cells.

Singh K, Poteryakhina A, Zheltukhin A, Bhatelia K, Prajapati P, Sripada L, Tomar D, Singh R, Singh AK, Chumakov PM, Singh R.

Biochim Biophys Acta. 2015 May;1853(5):1073-86. doi: 10.1016/j.bbamcr.2015.01.016. Epub 2015 Jan 30.

26.

A sustained deficiency of mitochondrial respiratory complex III induces an apoptotic cell death through the p53-mediated inhibition of pro-survival activities of the activating transcription factor 4.

Evstafieva AG, Garaeva AA, Khutornenko AA, Klepikova AV, Logacheva MD, Penin AA, Novakovsky GE, Kovaleva IE, Chumakov PM.

Cell Death Dis. 2014 Nov 6;5:e1511. doi: 10.1038/cddis.2014.469.

27.

The Role of Dihydroorotate Dehydrogenase in Apoptosis Induction in Response to Inhibition of the Mitochondrial Respiratory Chain Complex III.

Khutornenko AA, Dalina AA, Chernyak BV, Chumakov PM, Evstafieva AG.

Acta Naturae. 2014 Jan;6(1):69-75.

28.

Generation of iPS Cells from Human Hair Follice Dermal Papilla Cells.

Muchkaeva IA, Dashinimaev EB, Artyuhov AS, Myagkova EP, Vorotelyak EA, Yegorov YY, Vishnyakova KS, Kravchenko IE, Chumakov PM, Terskikh VV, Vasiliev AV.

Acta Naturae. 2014 Jan;6(1):45-53.

29.

Prooxidant properties of p66shc are mediated by mitochondria in human cells.

Galimov ER, Chernyak BV, Sidorenko AS, Tereshkova AV, Chumakov PM.

PLoS One. 2014 Mar 11;9(3):e86521. doi: 10.1371/journal.pone.0086521. eCollection 2014.

30.

The tumor suppressor p53 fine-tunes reactive oxygen species levels and neurogenesis via PI3 kinase signaling.

Forsberg K, Wuttke A, Quadrato G, Chumakov PM, Wizenmann A, Di Giovanni S.

J Neurosci. 2013 Sep 4;33(36):14318-30. doi: 10.1523/JNEUROSCI.1056-13.2013.

31.

[Apoptin enhances the oncolytic activity of vaccinia virus].

Kochneva GV, Babkina IN, Lupan TA, Grazhdantseva AA, Iudin PV, Sivolobova GF, Shvalov AN, Popov EG, Babkin IV, Netesov SV, Chumakov PM.

Mol Biol (Mosk). 2013 Sep-Oct;47(5):842-52. Russian.

32.

[Oncolytic viruses in the therapy of gliomas].

Gubanova NV, Gaĭtan AS, Razumov IA, Mordvinov VA, Krivoshapkin AL, Netesov SV, Chumakov PM.

Mol Biol (Mosk). 2012 Nov-Dec;46(6):874-86. Russian.

PMID:
23350233
33.

[Oncolytic properties of some orthopoxviruses, adenoviruses and parvoviruses in human glioma cells].

Razumov IA, Sviatchenko VA, Protopopova EV, Kochneva GV, Kiselev NN, Gubanova NV, Shilov AG, Mordvinov VA, Netesov SV, Chumakov PM, Loktev VB.

Vestn Ross Akad Med Nauk. 2013;(12):4-8. Russian.

PMID:
24741936
34.

[Oncolytic enteroviruses].

Chumakov PM, Morozova VV, Babkin IV, Baĭkov IK, Netesov SV, Tikunova NV.

Mol Biol (Mosk). 2012 Sep-Oct;46(5):712-25. Review. Russian.

PMID:
23156670
35.

[Protein complementation as tool for studying protein-protein interactions in living cells].

Chumakov SP, Kravchenko IuE, Chumakov PM.

Mol Biol (Mosk). 2012 Sep-Oct;46(5):699-711. Review. Russian.

PMID:
23156669
36.

[Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives].

Sviatchenko VA, Tarasova MV, Netesov SV, Chumakov PM.

Mol Biol (Mosk). 2012 Jul-Aug;46(4):556-69. Review. Russian.

PMID:
23113343
37.

[Oncolytic poxviruses].

Kochneva GV, Sivolobova GF, Iudina KV, Babkin IV, Chumakov PM, Netesov SV.

Mol Gen Mikrobiol Virusol. 2012;(1):8-15. Review. Russian.

PMID:
22702138
38.

[Oncolytic parvoviruses. A new approaches for cancer therapy].

Loktev VB, Ivan'kina TIu, Netesov SV, Chumakov PM.

Vestn Ross Akad Med Nauk. 2012;(2):42-7. Review. Russian.

PMID:
22642177
39.

[P66shc action on resistance of colon carcinoma RKO cells to oxidative stress].

Galimov ER, Sidorenko AS, Tereshkova AV, Pletiushkina OIu, Cherniak BV, Chumakov PM.

Mol Biol (Mosk). 2012 Jan-Feb;46(1):139-46. Russian.

PMID:
22642111
40.

Actin cytoskeleton remodeling by the alternatively spliced isoform of PDLIM4/RIL protein.

Guryanova OA, Drazba JA, Frolova EI, Chumakov PM.

J Biol Chem. 2011 Jul 29;286(30):26849-59. doi: 10.1074/jbc.M111.241554. Epub 2011 Jun 2.

41.

Constitutive and induced functions of the p53 gene.

Zheltukhin AO, Chumakov PM.

Biochemistry (Mosc). 2010 Dec;75(13):1692-721. Review.

42.

[Downregulation of activated leukemic oncogenes AML1-ETO and RUNX1(K83N) expression with RNA-interference].

Spirin PV, Baskaran F, Orlova NN, Rulina AV, Nikitenko NA, Chernolovskaia EL, Zenkova MA, Vlasov VV, Rubtsov PM, Chumakov PM, Stocking C, Prasolov VS.

Mol Biol (Mosk). 2010 Sep-Oct;44(5):876-88. Russian.

PMID:
21090242
43.

Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway.

Khutornenko AA, Roudko VV, Chernyak BV, Vartapetian AB, Chumakov PM, Evstafieva AG.

Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):12828-33. doi: 10.1073/pnas.0910885107. Epub 2010 Jun 21.

44.

Efficient downregulation of multiple mRNA targets with a single shRNA-expressing lentiviral vector.

Chumakov SP, Kravchenko JE, Prassolov VS, Frolova EI, Chumakov PM.

Plasmid. 2010 May;63(3):143-9. doi: 10.1016/j.plasmid.2009.12.003. Epub 2010 Jan 11.

45.

[A lentivirus vector based assay system for quantitative detection of intracellular translocations of recombinant proteins].

Chumakov SP, Il'inskaia GV, Kravchenko IuE, Frolova EI, Prasolov VS, Chumakov PM.

Mol Biol (Mosk). 2008 Nov-Dec;42(6):1004-11. Russian.

46.

Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense.

Olovnikov IA, Kravchenko JE, Chumakov PM.

Semin Cancer Biol. 2009 Feb;19(1):32-41. doi: 10.1016/j.semcancer.2008.11.005. Epub 2008 Dec 3. Review.

47.

Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway.

Kravchenko JE, Ilyinskaya GV, Komarov PG, Agapova LS, Kochetkov DV, Strom E, Frolova EI, Kovriga I, Gudkov AV, Feinstein E, Chumakov PM.

Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6302-7. doi: 10.1073/pnas.0802091105. Epub 2008 Apr 18.

48.

[The use of p53 as a tool for human cancer therapy].

Almazov VP, Kochetkov DV, Chumakov PM.

Mol Biol (Mosk). 2007 Nov-Dec;41(6):947-63. Review. Russian.

49.

Versatile functions of p53 protein in multicellular organisms.

Chumakov PM.

Biochemistry (Mosc). 2007 Dec;72(13):1399-421. Review.

50.

[Transcriptional inhibition of human papilloma virus in cervical carcinoma cells reactivates functions of the tumor suppressor p53].

Kochetkov DV, Il'inskaia GV, Komarov PG, Strom E, Agapova LS, Ivanov AV, Budanov AV, Frolova EI, Chumakov PM.

Mol Biol (Mosk). 2007 May-Jun;41(3):515-23. Russian.

Supplemental Content

Loading ...
Support Center